Beaver Sandra 4
4 · TANDEM DIABETES CARE INC · Filed May 22, 2026
Research Summary
AI-generated summary of this filing
Tandem Diabetes (TNDM) Director Sandra Beaver Receives Award
What Happened
Sandra Beaver, a director of Tandem Diabetes Care, Inc. (TNDM), received a grant of 5,110 restricted stock units (RSUs) on May 20, 2026. The award shows $0.00 cash paid (a grant/derivative award). The RSUs represent contingent rights to receive one share (or cash in lieu) at the issuer's discretion when they vest.
Key Details
- Transaction type: Award/Grant (derivative RSUs) recorded 2026-05-20; Form 4 filed 2026-05-22 (timely).
- Quantity: 5,110 RSUs; reported acquisition price $0.00 (grant).
- Vesting: These RSUs were granted May 20, 2026 and vest on the one-year anniversary (May 20, 2027), subject to the 2023 Long-Term Incentive Plan (footnotes F1–F2).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Remarks: Filing includes Exhibit 24 (Power of Attorney).
Context
RSU grants are a common form of compensation for directors and executives and do not involve an immediate purchase or sale of stock. Because these are time-vesting awards, they do not necessarily signal near-term buying or selling intent; they simply represent future potential equity compensation subject to vesting and plan terms.
Insider Transaction Report
- Award
Restricted Stock Unit
[F1][F2]2026-05-20+5,110→ 5,110 total→ Common Stock (5,110 underlying)
Footnotes (2)
- [F1]Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F2]Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.